UK markets close in 5 hours 34 minutes
  • FTSE 100

    7,522.90
    +4.55 (+0.06%)
     
  • FTSE 250

    20,168.19
    +102.60 (+0.51%)
     
  • AIM

    962.30
    +0.58 (+0.06%)
     
  • GBP/EUR

    1.1793
    -0.0041 (-0.34%)
     
  • GBP/USD

    1.2405
    -0.0088 (-0.70%)
     
  • BTC-GBP

    24,125.21
    -635.80 (-2.57%)
     
  • CMC Crypto 200

    671.66
    +428.98 (+176.77%)
     
  • S&P 500

    4,088.85
    +80.84 (+2.02%)
     
  • DOW

    32,654.59
    +431.17 (+1.34%)
     
  • CRUDE OIL

    114.14
    +1.74 (+1.55%)
     
  • GOLD FUTURES

    1,817.90
    -1.00 (-0.05%)
     
  • NIKKEI 225

    26,911.20
    +251.45 (+0.94%)
     
  • HANG SENG

    20,644.28
    +41.76 (+0.20%)
     
  • DAX

    14,188.71
    +2.77 (+0.02%)
     
  • CAC 40

    6,419.99
    -10.20 (-0.16%)
     

HAEMATO AG: Dividend of EUR 1.10

  • Oops!
    Something went wrong.
    Please try again later.
·2-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

HAEMATO AG / Key word(s): Dividend
HAEMATO AG: Dividend of EUR 1.10

03-May-2022 / 14:56 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

______________________________________________________________________________

HAEMATO AG: Dividend of EUR 1.10

Berlin, May 3, 2022 - At today's balance sheet meeting, the annual financial statements 2021 of HAEMATO AG, which were issued with an unqualified audit certificate, were adopted. The preliminary figures were confirmed. The Executive Board and Supervisory Board will propose a dividend of EUR 1.10 per dividend-bearing share to the Annual General Meeting to be held in presence on July 12, 2022.

About HAEMATO:

HAEMATO AG was founded in 1993 and is a pharmaceutical company focusing on the trade of high-priced specialty pharmaceutical drugs (with the therapeutic focus on oncology, HIV, rheumatology and other chronic diseases) as well as the development and distribution of medical products and private brands, especially in the area of "Lifestyle & Aesthetics". HAEMATO AG is listed on the Basic Board (Open Market) of the Frankfurt Stock Exchange. For further information, please visit www.haemato.de.




Contact:
HAEMATO AG, Investor Relations
Telefon: +49 (0)30 897 30 86 70
ir@haemato.ag

03-May-2022 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language:

English

Company:

HAEMATO AG

Lilienthalstraße 5c

12529 Schönefeld

Germany

Phone:

+49 (0)30 897 30 86 70

Fax:

+49 (0)30 897 30 86 79

E-mail:

ir@haemato.ag

Internet:

www.haemato.ag

ISIN:

DE000A289VV1

WKN:

A289VV

Listed:

Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Hamburg, Stuttgart, Tradegate Exchange

EQS News ID:

1342367


 

End of Announcement

DGAP News Service

show this
show this
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting